Director Petersen buys 12,500 PSTV shares at $1.35; prior same-ticker buys showed 90d returns of +2779.9% and +3012.0%.
Petersen Greg, a director, purchased 12,500 shares of PLUS THERAPEUTICS at $1.35 on 2024-09-11, increasing his holdings by 34.3% to 48.9K shares. His prior two buys at this same ticker on 2024-05-08 and 2023-09-11 generated 90-day returns of +2779.9% and +3012.0% respectively, establishing a pattern of exceptionally well-timed entry points at PSTV. The current filing occurs alongside a cluster of 4 other insiders buying within the past 14 days, suggesting coordinated confidence at the company level. While the stock is currently -43.7% from its 52-week high and the company reports unprofitability (net income $-2.9M) against quarterly revenue of $703.0K, the director's historical execution at this specific ticker—achieving two consecutive large 90-day gains—warrants attention to whether this third buy mirrors the same market conditions that preceded those prior rallies.